Dehaier Medical Awarded Five Export Certificates to Distribute Homecare Medical Products Overseas

BEIJING. August 15, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced it was granted export certificates for five homecare medical products by the State Food and Drug Administration ("SFDA") of the PRC.

The certificates, which were issued in June 2011 and are valid for two years, allow for Dehaier's Sleep Diagnostics product DHR-998, Dehaier Continuous Positive Airway Pressure ("CPAP") products - DHR-AUTO-A8, C5, and C6, and the Dehaier Medical Air Compressor - to be exported without restriction, and serve as validation that the products meet PRC government requirements for sale and shipment overseas. Those certificates are necessary because it is prerequisite for certain countries.

The Company also today announced that it was awarded a new design patent for its sleep diagnostics products by the State Intellectual Property Office ("SIPO") of the PRC. The new design patent, issued in July 2011 and valid for 10 years, increases the Dehaier intellectual property portfolio to six patents and five software copyrights, as well as proprietary technology.

"We are making progress toward expanding our business beyond China's borders, and believe the award of these export certificates is a critical first step to extending our geographic footprint," said Mr. Ping Chen, CEO of Dehaier. "Moreover, we are committed to investing in ongoing innovation, as we look to expand our addressable market through current product enhancements and new product introductions. We believe such a strategy will enable Dehaier to achieve its goal of meeting our customers' individual needs with a growing selection of homecare products."

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents and five software copyrights; additionally, we have two pending patents and six pending software copyrights, and proprietary technology. More information may be found at http://www.chinadhr.com.

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.